Improving the dissolution properties of spironolactone using liquisolid technique

Improving the dissolution properties of spironolactone using liquisolid technique

In this study the effect of liquisolid technique on the dissolution profile of spironolactone was evaluated. Different formulations of spironolactone liquisolid compacts were prepared using various amounts of non-volatile vehicles (Poly ethylene glycol 400 and glycerin). The ratio of microcrystallin...

Full description

Bibliographic Details
Main Authors:	Jafar Akbari, Majid Saeedi, Katayoun Morteza-Semnani, Zaynab Sadeghi Ghadi, Seyed Saeed Hosseini
Format:	Article
Language:	English
Published:	Mazandaran University of Medical Sciences 2015-09-01
Series:	Pharmaceutical and Biomedical Research
Subjects:	Spironolactone liquisolid technique dissolution rate PEG 400
Online Access:	http://pbr.mazums.ac.ir/browse.php?a_code=A-10-26-24&slc_lang=en&sid=1

Similar Items

Effect of glycerin on indomethacin release profile from their liquisolid compacts
by: Majid Saeedi, et al.
Published: (2009-01-01)

Enhancement of Loperamide Dissolution Rate by Liquisolid Compact Technique
by: Kambham Venkateswarlu, et al.
Published: (2016-09-01)

Liquisolid Tablets Formulation of Atorvastatin Calcium Using Polyethylene Glycol 400 as Solvent and Some Carrier Materials
by: Yulias Ninik Windriyati, et al.
Published: (2020-12-01)

Use of the liquisolid compact technique for improvement of the dissolution rate of valsartan
by: Naveen Chella, et al.
Published: (2012-10-01)

Enhancement of dissolution rate of racecadotril by liquisolid compact technology
by: Bhaskar Daravath, et al.
Published: (2023-01-01)

Dissolution enhancement of leflunomide incorporating self emulsifying drug delivery systems and liquisolid concepts
by: Nihal M. El-Mahdy El-Sayyad, et al.
Published: (2017-06-01)

Liquigroud technique: a new concept for enhancing dissolution rate of glibenclamide by combination of liquisolid and co-grinding technologies
by: Leila Azharshekoufeh, et al.
Published: (2017-02-01)

Development and Characterization of Liquisolid Tablets Based on Mesoporous Clays or Silicas for Improving Glyburide Dissolution
by: Marzia Cirri, et al.
Published: (2020-06-01)

Analysis of spironolactone polymorphs in active pharmaceutical ingredients and their effect on tablet dissolution profiles
by: Renata Cunha de Resende, et al.

Improvement of The Photostability of Nimodipine by Using Liquisolid Compacts Technique
by: Mustafa E. Khazim, et al.
Published: (2021-11-01)

Preparation and In-Vitro Evaluation of Clopidogrel Bisulfate Liquisolid Compact
by: Amina M. Mohammed, et al.
Published: (2018-12-01)

Attempts and outcomes of liquisolid technology: An updated chronological compilation of innovative ideas and adjuvants in the field
by: Vijay Sharma, et al.
Published: (2016-01-01)

Systematic Development of Self-Nanoemulsifying Liquisolid Tablets to Improve the Dissolution and Oral Bioavailability of an Oily Drug, Vitamin K1
by: Yongtao Tong, et al.
Published: (2018-07-01)

Solubility enhancement study of lumefantrine by formulation of liquisolid compact using mesoporous silica as a novel adsorbent
by: Sayani Bhattacharyya, et al.
Published: (2022-12-01)

Investigating the Effect of Coated Lipid Nano Particles of Spironolactone with Chitosan on Their Properties
by: Reza Enayatifard, et al.
Published: (2018-07-01)

Investigating the Effect of Mixed Surfactants with Different HLBs on the Properties of Solid Lipid Nanoparticle of Spironolactone
by: Zhila Imani, et al.
Published: (2018-07-01)

Clinical Pharmacokinetic Evaluation of Optimized Liquisolid Tablets as a Potential Therapy for Male Sexual Dysfunction
by: Fayez O. Alotaibi, et al.
Published: (2020-12-01)

Green Formulation of Spironolactone Loaded Chitosan-Coated Nano Lipid Carrier for Treatment of Acne Vulgaris: A Randomized Double-Blind Clinical Trial
by: Majid Saeedi, et al.
Published: (2024-03-01)

Formulation and Characterization of Eplerenone Nanoemulsion Liquisolids, An Oral Delivery System with Higher Release Rate and Improved Bioavailability
by: Ahmed Khames
Published: (2019-01-01)

Formulation and optimization of liquisolid compact for enhancing dissolution properties of efavirenz by using DoE approach
by: Bhola Jaydip, et al.
Published: (2020-06-01)

Spironolactone-Induced Agranulocytosis: A Case Report
by: Shu-Hwa Hsiao, et al.
Published: (2003-11-01)

Using fluid bed granulation to improve the dissolution of poorly water-soluble drugs
by: Andrea Ikeda Takahashi, et al.
Published: (2012-06-01)

Enhancement of the Oral Bioavailability of Fexofenadine Hydrochloride via Cremophor® El-Based Liquisolid Tablets
by: Soad Ali Yehia, et al.
Published: (2015-11-01)

Novel role of spironolactone in the therapy of resistant hypertension: Spironolactone and resistant hypertension
by: Dragojević-Simić Viktorija, et al.
Published: (2019-01-01)

Comparative evaluation of captopril, spironolactone, and carvedilol effect on endothelial function in breast cancer women undergoing chemotherapy
by: Seyed Mohammad Hashemi Jazi, et al.
Published: (2023-01-01)

The paradox of spironolactone: A heart failure treatment with potentially harmful effects
by: Muhammad Roshan, et al.
Published: (2024-01-01)

The paradox of spironolactone: A heart failure treatment with potentially harmful effects
by: Muhammad Roshan, et al.
Published: (2024-01-01)

Influences of Glimepiride Self-Nanoemulsifying Drug Delivery System Loaded Liquisolid Tablets on the Hypoglycemic Activity and Pancreatic Histopathological Changes in Streptozotocin-Induced Hyperglycemic Rats
by: Tarek A. Ahmed, et al.
Published: (2022-11-01)

Investigation of the effect of solubility increase at the main absorption site on bioavailability of BCS class II drug (risperidone) using liquisolid technique
by: Ahmed Khames
Published: (2017-01-01)

Studies on Preformulation and Formulation of JIN-001 Liquisolid Tablet with Enhanced Solubility
by: Han-Sol Kim, et al.
Published: (2022-03-01)

The Liquisolid technique: an overview
by: Shashidher Burra, et al.
Published: (2011-09-01)

Possible role of Spironolactone in a sample of Iraqi patients with acute central serous chorioretinopathy
by: Marwa Majeed Hameed, et al.
Published: (2022-05-01)

Spironolactone mitigates, but does not reverse, the progression of renal fibrosis in a transgenic hypertensive rat
by: Catherine J. Leader, et al.
Published: (2020-05-01)

The Effect of Spironolactone on Control of Pulmonary Hypertension in Patients with Obstructive Pulmonary Disease
by: Mohammad Emami, et al.
Published: (2019-01-01)

Effects of Spironolactone in Combination with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Proteinuria
by: Ha Yeon Kim, et al.
Published: (2014-12-01)

Association of spironolactone treatment and arterial stiffness and cardiovascular disease in hypertensive patients
by: Fanfang Zeng, et al.
Published: (2019-06-01)

Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case
by: Kapil G. Kapoor, et al.
Published: (2017-07-01)

Compatibility determination of potassium orotate with spironolactone by high-performance liquid chromatography
by: Ecaterina Mazur, et al.
Published: (2020-10-01)

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
by: Ivan Velat, et al.
Published: (2020-08-01)

Application of Machine-Learning Algorithms for Better Understanding the Properties of Liquisolid Systems Prepared with Three Mesoporous Silica Based Carriers
by: Teodora Glišić, et al.
Published: (2023-02-01)